Cargando…

Waning of 2-Dose BNT162b2 and mRNA-1273 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Accounting for Depletion-of-Susceptibles Bias

Concerns about the duration of protection conferred by coronavirus disease 2019 (COVID-19) vaccines have arisen in postlicensure evaluations. “Depletion of susceptibles,” a bias driven by differential accrual of infection among vaccinated and unvaccinated individuals, may obscure vaccine effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrejko, Kristin L, Pry, Jake M, Myers, Jennifer F, Mehrotra, Megha, Lamba, Katherine, Lim, Esther, Fukui, Nozomi, DeGuzman, Jennifer L, Openshaw, John, Watt, James, Jain, Seema, Lewnard, Joseph A, COVID-19 Case-Control Study Team, on behalf of the California
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236522/ https://www.ncbi.nlm.nih.gov/pubmed/36702469 http://dx.doi.org/10.1093/aje/kwad017

Ejemplares similares

Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: A registry-linkage study
por: Andrejko, Kristin L., et al.
Publicado: (2023)

Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California
por: Andrejko, Kristin L, et al.
Publicado: (2021)

Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
por: Andrejko, Kristin L, et al.
Publicado: (2021)

Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021–2022 influenza season
por: Andrejko, Kristin L., et al.
Publicado: (2023)

Protocol for the Management of Asymptomatic Persons Infected with COVID-19 Virus
por: Joint Taskforce on COVID-19 Prevention and Control, China State Council,
Publicado: (2020)

Local Outbreak of COVID-19 in Shunyi District Attributed to an Asymptomatic Carrier with a History of Stay in Indonesia — Beijing Municipality, China, December 23, 2020
por: COVID-19 Epidemiology Investigation Team,, et al.
Publicado: (2021)

Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Vaccine waning and mumps re-emergence in the USA
por: Lewnard, Joseph, et al.
Publicado: (2017)

Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection — California, February–December 2021
por: Andrejko, Kristin L., et al.
Publicado: (2022)

Business Intelligence applied to Emergency Medical Services in the Lombardy region during SARS-CoV-2 epidemic
por: Sechi, Giuseppe Maria, et al.
Publicado: (2020)

Risk Factors for Death Among Hospitalized Patients Aged 21–64 Years Diagnosed with COVID-19—New York City, March 13–April 9, 2020
por: Bushman, Dena, et al.
Publicado: (2021)

Technical Vaccination Recommendations for COVID-19 Vaccines in China (First Edition)
por: COVID-19 Vaccine Technical Working Group,
Publicado: (2021)

Establishment of the NIAC Technical Working Group on COVID-19 Vaccines
por: COVID-19 Vaccines Technical Working Group,
Publicado: (2020)

The Relationship Between Decreased CD-8 T-Cells and Mortality in Patients with COVID-19 Pneumonia in the Intensive Care Unit, A Retrospective Study
por: Sarıkaya, Zeynep Tuğçe, et al.
Publicado: (2023)

COVID-19 cases before and after the “I stay at home” decree, Bologna Local Health Authority, Italy
por: Stivanello, Elisa, et al.
Publicado: (2020)

Longitudinal social contacts among school-aged children during the COVID-19 pandemic: the Bay Area Contacts among Kids (BACK) study
por: Andrejko, Kristin L., et al.
Publicado: (2022)

The Waning of the Plague
Publicado: (1897)

COVID-19 mRNA vaccination in patients with previous myocarditis
por: Pieroni, Maurizio, et al.
Publicado: (2022)

Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
por: Tré-Hardy, Marie, et al.
Publicado: (2021)

Waning antibodies to SARS-CoV-2 – Don't panic
por: Meyer, Benjamin
Publicado: (2021)

Full and Booster Doses of SARS-CoV-2 mRNA-1273 Vaccine Increase Waning Antibody Levels After Completed Vaccination Among Dialysis Patients at a Large Dialysis Organization
por: Ficociello, Linda H, et al.
Publicado: (2022)

mrna-1273: Haematuria: 2 case reports
Publicado: (2021)

Using social media as a platform to publicly disclose HIV status among people living with HIV: Control, identity, informing public dialogue
por: Philpot, Steven P., et al.
Publicado: (2022)

The waning war on cancer.
Publicado: (1995)

A Waning Superstition
Publicado: (1902)

Mental Disease on the Wane
por: Banschikov, Vasili, et al.
Publicado: (1965)

The Source of Infection of the 137(th) Confirmed Case of COVID-19 — Tianjin Municipality, China, June 17, 2020
por: COVID-19 Field Response Group,, et al.
Publicado: (2020)

Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021)

SARS-Cov-2 immune waning and reinfection in care-home settings
por: Altmann, Daniel M, et al.
Publicado: (2021)

Dynamics of SARS-CoV-2 with waning immunity in the UK population
por: Crellen, Thomas, et al.
Publicado: (2021)

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
por: Goldberg, Yair, et al.
Publicado: (2022)

Waning and boosting of functional humoral immunity to SARS-CoV-2
por: Tong, X., et al.
Publicado: (2022)

Waning immunity to SARS-CoV-2 following vaccination or infection
por: Hernandez-Suarez, Carlos, et al.
Publicado: (2022)

Immunogenicity of BNT162b2 Vaccination against SARS-CoV-2 Omicron Variant and Attitudes toward a COVID-19 Booster Dose among Healthy Thai Adolescents
por: Assavavongwaikit, Pavinee, et al.
Publicado: (2022)

Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report
por: Goldman, Jason D., et al.
Publicado: (2022)

RE: Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity
por: Duman, Dildar, et al.
Publicado: (2023)

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Waning of SARS-CoV-2 booster viral-load reduction effectiveness
por: Levine-Tiefenbrun, Matan, et al.
Publicado: (2022)

Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pv4l42p7vgo5diuatmlamkpc7f